PATENT CLAIM ANALYSIS

Application Number: 16260989
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["424", "489000"]

Abstract:
Formulations and methods are provided for improving the function, i.e. clinical outcome, of solid organ transplants. Lung transplantation is of particular interest. In the methods of the invention, a nanoparticle formulation comprising an effective dose of an iron chelator active agent in nanoparticle form, including without limitation, deferoxamine (DFO), deferasirox (DFX), and deferiprone (DFP), etc. suspended in a carrier compatible with the tissue of interest, is topically applied to the surface of tissues at the site of anastomosis. The nanoparticles are comprised of the active agent and a pharmaceutically acceptable stabilizer.

Claim (Index 44):
The method of  claim 38 , wherein the carrier provides for nanoparticle penetration to a depth of at least about 1 mm over a period of time up to about 30 minutes.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.62319
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14424994', '14653245', '12515722', '15623898', '14063179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7587703090842146
- 35 USC 102 Novelty (BERT): 0.6738627395036856
- Combined Prediction Score: 0.7502795521261617
- Mean Citation Score: 400.934376
- Max Citation Score: 731.7169
- Similarity Product: 635.446665497911

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test